Jpmorgan Chase & CO Neuro Pace Inc Transaction History

Jpmorgan Chase & CO

  • $1.27 Trillion
  • Q1 2025

A detailed history of Jpmorgan Chase & CO transactions in Neuro Pace Inc stock. As of the latest transaction made, Jpmorgan Chase & CO holds 43,792 shares of NPCE stock, worth $450,181. This represents 0.0% of its overall portfolio holdings.

Number of Shares
43,792
Previous 64,826 32.45%
Holding current value
$450,181
Previous $725,000 25.79%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 12, 2025
SELL
$10.04 - $14.94 $211,181 - $314,247
-21,034 Reduced 32.45%
43,792 $538,000
Q4 2024

Feb 12, 2025
BUY
$5.9 - $11.93 $311,691 - $630,249
52,829 Added 440.35%
64,826 $725,000
Q3 2024

Dec 26, 2024
BUY
$6.65 - $8.46 $41,103 - $52,291
6,181 Added 106.28%
11,997 $83,000
Q3 2024

Nov 08, 2024
BUY
$6.65 - $8.46 $41,103 - $52,291
6,181 Added 106.28%
11,997 $83,000
Q2 2024

Dec 26, 2024
SELL
$6.38 - $15.33 $39,434 - $94,754
-6,181 Reduced 51.52%
5,816 $43,000
Q2 2024

Aug 12, 2024
SELL
$6.38 - $15.33 $167,787 - $403,163
-26,299 Reduced 81.89%
5,816 $43,000
Q1 2024

Dec 26, 2024
BUY
$9.78 - $17.5 $196,754 - $352,065
20,118 Added 167.69%
32,115 $423,000
Q1 2024

May 10, 2024
BUY
$9.78 - $17.5 $202,983 - $363,212
20,755 Added 182.7%
32,115 $423,000
Q4 2023

Dec 26, 2024
SELL
$5.9 - $10.31 $3,758 - $6,567
-637 Reduced 5.31%
11,360 $117,000
Q4 2023

Feb 12, 2024
BUY
$5.9 - $10.31 $67,024 - $117,121
11,360 New
11,360 $117,000
Q2 2022

Aug 11, 2022
SELL
$4.95 - $8.7 $16,483 - $28,970
-3,330 Closed
0 $0
Q1 2022

May 11, 2022
SELL
$7.06 - $11.57 $11,451 - $18,766
-1,622 Reduced 32.75%
3,330 $27,000
Q4 2021

Feb 10, 2022
BUY
$8.63 - $17.36 $19,659 - $39,546
2,278 Added 85.19%
4,952 $50,000
Q3 2021

Nov 12, 2021
BUY
$15.85 - $25.07 $42,382 - $67,037
2,674 New
2,674 $42,000

Others Institutions Holding NPCE

# of Institutions
107
Shares Held
21.4M
Call Options Held
3.14M
Put Options Held
68.6K
View Full List

About NeuroPace Inc

NPCE Quotes by TradingView
  • Ticker NPCE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,846,900
  • Market Cap $255M
  • Description
  • NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and ena...
More about NPCE
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email